Kerin Ablashi M.S.
|
Click To Contact
|
Phone: 240-683-0007
Expertise in project management, regulatory submissions |
|
|
|
Julia Barrett M.D., MPH
|
Click To Contact
|
Phone: 303-905-5383
Expertise in clinical product development, clinical trial design and execution, and FDA licensure requirements. |
|
|
|
John R. Godshalk MSE, MBA
|
Click To Contact
|
Phone: 703-485-6139
Expertise in cGMP compliance, facility design and regulatory requirements, quality assurance, audits/inspections |
|
|
|
Melanie T. Hartsough Ph.D.
|
Click To Contact
|
Phone: 301-742-3665
Expertise in nonclinical pharmacology and toxicology and preclinical development of biologic products |
|
|
|
John J. Jessop Ph.D., MPH
|
Click To Contact
|
Phone: 540-776-0680
Expertise in pharmacology-toxicology, regulatory affairs and product development for biologics and drugs |
|
|
|
Louise C. Johnson M.S.
|
Click To Contact
|
Phone: 650-740-4750
Expertise in regulatory affairs for investigational and marketed small molecules and investigational biotechnology products |
|
|
|
James G. Kenimer Ph.D.
|
Click To Contact
|
Phone: 703-739-5695
Expertise in regulatory strategy – FDA liaison |
|
|
|
David T. Lin Ph.D., MBA
|
Click To Contact
|
Phone: 301-299-2853
Expertise in CMC (quality), product development, and FDA submission requirements |
|
|
|
Ronald A. Marchesani
|
Click To Contact
|
Phone: 650-378-1303
Expertise in compliance audits, facility design evaluation and quality system development/evaluation/oversight for biotechnology products |
|
|
|
Andra E. Miller Ph.D.
|
Click To Contact
|
Phone: 301-320-9537
Expertise in CMC, regulatory and GMP requirements for cell and gene therapy products |
|
|
|
Peter A. Patriarca M.D.
|
Click To Contact
|
Phone: 301-233-3220
Expertise in biological product development, clinical evaluation, and product lifecycle management |
|
|
|
Peter Probst
|
Click To Contact
|
Phone: 301-831-3007
Expertise in GMP compliance; quality assurance; facility audits/inspections, facility validation & regulatory requirements; facility design evaluation |
|
|
|
Nadine M. Ritter Ph.D.
|
Click To Contact
|
Phone: 240-372-4898
Expertise in analytical CMC technical and regulatory requirements and R&D/GLP/GMP laboratory quality practices for biotechnology products |
|
|
|
Ronald A. Salerno Ph.D.
|
Click To Contact
|
Phone: 215-896-2067
Expertise in global regulatory strategy and registration for vaccines, biologics and drugs including application of pharmacogenomics and biomarkers for regulatory decision-making. |
|
|
|
Ann Sutton MPH
|
Click To Contact
|
Phone: 303-903-2097
Expertise in CMC, regulatory and product development for vaccines and live biotherapeutic products |
|
|
|
Michael A. Trapani MS, MBA
|
Click To Contact
|
Phone: 908-359-9519
Expertise in GCP, GLP and GMP audits, regulatory compliance and quality assurance/systems for biological and drug products |
|
|
|
Darin J. Weber Ph.D.
|
Click To Contact
|
Phone: 206-940-3923
Expertise in regulatory strategy and CMC development for cell-based therapies and engineered tissues |
|
|
|
Michael S. Williams
|
Click To Contact
|
Phone: 703-216-7944
Expertise in regulatory and product development for viral products, specializing in all aspects relating to influenza virus vaccines |
|
|
|
Larry K. Winberry Ph.D.
|
Click To Contact
|
Phone: 248-396-5818
Expertise in quality systems, manufacture and control, and product development for biological products |
|
|
|
Ruth Wolff Ph.D.
|
Click To Contact
|
Phone: 301-921-4160
|
|
|
|
Michael Gross Ph.D, RAC
|
Click To Contact
|
Phone: 215-316-8394
Expertise in quality and regulatory affairs for drugs, biologics, medical devices, specializing in combination products. |
|
|
|
Calley Herzog
|
Click To Contact
|
Phone: 720-883-3633
Expertise in regulatory project management for all types of premarket submissions. |
|
|
|
Blair A. Fraser Ph.D.
|
Click To Contact
|
Phone: 240-477-7826
Expertise in CMC (quality), drug and biologic product development and FDA submissions. |
|
|
|